-Manage the organization's oncology Tumor Prioritization process by coordinating with marketing stakeholders (i.e., Finance, data & analytics, Forecasting, etc.) and cross-functional team members to support the generation of outputs and socialization materials
-Assist in the evolution of the financial model based on business needs and market challenges to drive prioritization of pipeline assets to optimize allocation of resources and investments appropriately
-Provide guidance to marketing brand teams for strategic and tactical business planning including development and execution of a detailed timelines, communication plans, and tailoring of materials/templates to support the annual planning cycle
-Developed the annual investment story for US Oncology for senior leadership; acted as a liaison between leadership and marketing stakeholders during tradeoff discussions for investment/resource allocation

Market access consultant duties: Completed 20+ KOL interviews (moderator & transcriber) with payers (i.e., PBMs, IDNs, and MCOs); performed qualitative and quantitative analysis via Qualtrics surveys; and created client decks.

• Utilize data management tools to evaluate hospital financial systems and operations to identify areas of risk within revenue cycles
• Collaborate with client Marshfield Clinic Health System C-level executives to improve provider revenue performance by evaluating payer contracting and reimbursement negotiations and strategies
• Contributed 49% toward a team revenue recovery goal of $150,000 in Q1 2020 and 58% toward team recovery goal of $400,000

Primary market access consultant duties: performed extensive market research on pharma manufacturer copay cards for specific therapeutic areas (i.e., rheumatology, neurology, dermatology, and ophthalmology) and created client decks/deliverables.

Performed competitive intelligence in the diagnostic space for a large biotech company. Consultant duties include: KOL interview moderator & transcriber, financial analyses (revenue projections, market share, etc.), organizational analysis, client decks/deliverables, and interim/final readouts.

• Confirmed significant unmet need in women’s health pertaining to endometriosis by exploring
potential biomarkers and establishing relevance of Hologic-owned technologies
• Evaluated new pipeline therapies that yield expanded opportunity by validating Hologic U.S.
OB/GYN channel aids in developing market and altering standard of care

• Examined the market landscape surrounding potential use cases for Poseidon’s technology,
and investigate the marketplace surrounding existing indications being served by monoclonal
antibodies
• Estimated the addressable market for a potential product launch by Poseidon, and identify
potential partnering opportunities for Poseidon within prioritized markets

• Executed quality control through data analysis by prescreening press releases and SEC earnings report from biotech and pharmaceutical companies
• Evaluated pipeline, deals, and market data of biotech/biopharma companies using BioCentury BCIQ database

Performed a precedent transaction analysis of biopharma companies with suitable and lucrative pipelines in preparation for negotiations
• Conducted interviews with Key Opinion Leaders in healthcare to identify commercially viable rare diseases
• Communicated with directors of different departments to compile internal information onto a shared data room for potential deals with external companies